Polyclonal Antibodies

Articles

A Review of the SARS-CoV-2 (COVID-19) Genome and Proteome

GeneTex is proud to offer an extensive line of reagents to support the study of SARS-CoV-2 / COVID-19.

Articles

Five Pillars of Antibody Validation

GeneTex employs various analytic validation strategies to ensure both consistent quality and specificity.

Articles

The concept of a SARS-CoV-2 / COVID-19 rapid test

A rapid virus antigen test detects SARS-CoV-2 particles in samples by capturing viral antigen between a free labeled antibody and a fixed second antibody that each recognize different regions of the antigen.

Articles

beta Amyloid

GeneTex’s “beta-Amyloid (1-42) antibody – Conformation-Specific” can specifically detect amyloid plaques in the Alzheimer's Disease brain by IHC-P analysis. The superior specificity and sensitivity of this antibody were confirmed by dot blot, ELISA and side-by-side IHC-P comparison with competitor's.

Articles

Approach to Antibody Lot-to-Lot Variability

Lot-to-lot variability is a persistent quality control (QC) issue that contributes to inconsistent results in assays using antibodies.

Articles

Overexpression Antibodies

The validity of a target protein’s endogenous signal can be further substantiated through overexpression of that protein using a recombinant construct.

Articles

Orthogonal_Antibodies

Detecting predicted changes in the antibody-generated signal due to alteration of experimental biological conditions is a reliable approach to gauge antibody performance.

Articles

IP/MS-antibodies

Using mass spectrometry (MS) to identify the protein(s) bound by an antibody is a powerful method for the validation of antibody specificity and performance.

Articles

Knockdown Technology

RNA interference (RNAi) refers to a cellular mechanism of post-transcriptional gene regulation through the actions of non-coding microRNAs (miRNAs).

Articles

Background of CRISPR/Cas9 technology

The RNA-guided CRISPR/Cas9 system is a revolutionary genome editing tool derived from the bacterial Type II CRISPR adaptive immune system.

Articles

Knockout/Knockdown Validation

GeneTex is conducting knockout/knockdown-based validation as a fundamental component of its antibody quality assurance process.

Articles

ResponsibleScientists.org

An Open Letter Regarding Climate Change From Concerned Members of the U.S. National Academy of Sciences

Pathways

Epithelial–mesenchymal transition (EMT) Pathway

EMT is a process whereby tightly-interacting and immotile epithelial cells acquire the phenotype of loosely-adherent and motile mesenchymal cells.

Pathways

Autophagy Pathway

Autophagy is the process of self-cannibalization of cellular proteins or organelles through lysosomal degradation.

Pathways

Bcl-2 Pathway

B-cell lymphoma-2 (Bcl-2)-family proteins play an important role in regulating the induction of apoptosis.

Pathways

Notch Pathway

The Notch signaling pathway is an important evolutionarily conserved pathway that plays a vital role in the regulation of asymmetric cell division, cell fate specification, proliferation and apoptosis during development.

Pathways

Apoptosis Pathway

Pathways

Cell Cycle Pathway

Pathways

Histone Code

Pathways

JAK-STAT Pathway

Pathways

Hypoxia Pathway

Hypoxia in tumors is closely associated with tumor aggressiveness and resistance to radio- and chemotherapeutic treatment.

Pathways

ER Stress Pathway

Newsletter

GeneTex’s “5 + 1” Pillar Antibody Validation Plan

Newsletter

Omicron BQ.1 and BF.7 Spike and Nucleocapsid Recombinant Proteins

Newsletter

The SARS-CoV-2 Omicron Variant

The SARS-CoV-2 Omicron Variant

Newsletter

A Rising StAR in Cancer Research

Steroidogenic acute regulatory protein 1 (StAR/StARD1) mediates the rate-limiting step in steroidogenesis...

Newsletter

SARS-CoV-2-directed T cell Response in Convalescent and Vaccinated Individuals

SARS-CoV-2-directed T cell Response in Convalescent and Vaccinated Individuals

Newsletter

Influenza A and B Virus Recombinant Monoclonal Antibodies

Influenza A and B Virus Recombinant Monoclonal Antibodies

Newsletter

SARS-CoV-2 can infect the human brain

SARS-CoV-2 can infect the human brain

Newsletter

Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells

Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells

Newsletter

IHC- and FCM-validated Antibodies for SARS-CoV-2 Research

IHC- and FCM-validated Antibodies for SARS-CoV-2 Research

Newsletter

Lateral Flow Assay for Influenza & SARS-CoV-2 Viruses Detection

Influenza A & B Virus Antibodies (IVD grade)

Newsletter

New Therapeutic Paradigm for Cancers with Activated NRF2

New Therapeutic Paradigm for Cancers with Activated NRF2

Newsletter

Article alert: Proteomic Analysis Reveals How RNA Viruses Remodel Host Polysomes

Article alert: Proteomic Analysis Reveals How RNA Viruses Remodel Host Polysomes

Newsletter

Skin Regeneration without Scar Formation

Skin Regeneration without Scar Formation

Newsletter

mRNA Vaccine-induced Antibody Profiles against SARS-CoV-2 Variants

mRNA Vaccine-induced Antibody Profiles against SARS-CoV-2 Variants

Newsletter

GeneTex’s SARS-CoV-2 Spike RBD Antibodies Effectively Inhibit Viral Entry

GeneTex’s SARS-CoV-2 Spike RBD Antibodies Effectively Inhibit Viral Entry

Newsletter

Neuropilins Facilitate SARS-CoV-2 Entry into Host Cells

Neuropilins Facilitate SARS-CoV-2 Entry into Host Cells

Newsletter

Zika Virus Infection Increases Risk of Subsequent Severe Dengue Disease

Zika Virus Infection Increases Risk of Subsequent Severe Dengue Disease

Newsletter

Spike Antibody-mediated Neutralization of SARS-CoV-2

Spike Antibody-mediated Neutralization of SARS-CoV-2

Newsletter

Profiling cytokine storm in COVID-19 patients by metatranscriptomic sequencing

Profiling cytokine storm in COVID-19 patients by metatranscriptomic sequencing

Newsletter

GeneTex Introduces Recombinant Monoclonal Iba1 Antibody

GeneTex's Iba1 recombinant antibody is suitable for IHC staining and WB.

Newsletter

GeneTex Launches Novel Recombinant RAS (G12D Mutant) Antibody [HL10]

GeneTex's RAS (G12D mutant) recombinant antibody is suitable for IHC staining and WB.

Newsletter

Leaky blood-brain barrier triggers neural dysfunction that is reversible

Leaky blood-brain barrier triggers neural dysfunction that is reversible

Newsletter

GeneTex Partners With BenchSci to Augment Antibody Catalog Publication Data

Partnership will use BenchSci's artificial intelligence to help researchers run successful experiments with the right antibody

Newsletter

GeneTex Webinar Series

GeneTex Webinar Series

Newsletter

SARS-CoV-2 Proteins and Antibodies for Lateral Flow-based Neutralization Assay

for Lateral flow-based Neutralization Assay

Newsletter

A Cancer Immunotherapy Holy Grail?

A Cancer Immunotherapy Holy Grail?

Newsletter

MLLT3/AF9 is Pivotal for Human HSC Self-renewal and Engraftment

MLLT3/AF9 is Pivotal for Human HSC Self-renewal and Engraftment

Newsletter

Independent Knockout Validation of C9ORF72 Antibodies

Independent Knockout Validation of C9ORF72 Antibodies for the research of Amyotrophic lateral sclerosis.

Newsletter

Is ApoE the piece to complete the puzzle of Alzheimer’s disease?

ApoE was identified as a major checkpoint inhibitor of the classical complement cascade, and involved in a possible unifying mechanism underlying Alzheimer’s disease, atherosclerosis, and potentially other inflammatory diseases.

Newsletter

A Well-Cited Nrf2 Antibody for Cellular Redox Research

A quality Nrf2 antibody with multiple species reactivity for cellular redox research

Newsletter

Neurodegeneration: A "Vicious Cycle" Involving Mitochondria, Glia, and Neuronal Death

A "Vicious Cycle" Involving Mitochondria, Glia, and Neuronal Death

Newsletter

SETD3 Is Pivotal for Infection by Multiple Human Enteroviruses

In an exciting example of this concept, Diep et al. described the use of a genome-scale CRISPR screen to show that the protein histidine methyltransferase SETD3 is crucial for the replication of multiple human enteroviruses.

Newsletter

Soluble TREM2 is associated with clinical progression of Alzheimer’s disease.

A recent study by Ewers et al. reported that increased soluble TREM2 measured in cerebrospinal fluid was associated with lower rates of cognitive and clinical decline and progression in people with AD.

Newsletter

Adoptive T cell therapy shows potential to eliminate hepatitis B virus (HBV) infection.

Is a cure for chronic hepatitis B on the horizon? Adoptive T cell therapy shows potential to eliminate hepatitis B virus (HBV) infection.

Newsletter

Dogs Provide Great Help to Human Cancer Research

A large canine clinical trial was recently launched with the goal of developing a new cancer vaccine strategy that prevents tumor cells from developing into cancerous growths.

Newsletter

Improving cancer immunotherapy efficacy may depend on targeting exosomes

Improving cancer immunotherapy efficacy may depend on targeting exosomes bearing the immune checkpoint protein PD-L1

Promotion

Antibodies in trial size. 25μl package available now!

Our most popular antibodies now come in 25μl packaging.